Entasobulin 是一种 β-微管蛋白聚合的抑制剂，具有潜在的抗癌活性。

Entasobulin is an inhibitor of β-tubulin polymerization. It has a potential anticancer activity.

Entasobulin is an indolizine-glyoxylamide based small molecule. It shows substantial in vitro anti-proliferative activities against cancer cell lines, including multidrug resistance (MDR) phenotypes.

501921-61-5

C26H18ClN3O2

439.89

Entasobulin

DMSO:155 mg/mL (352.36 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years